The challenges on developing vaccine against visceral leishmaniasis.
Departamento de Bioquímica, Centro de Biociências, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.|Departamento de Bioquímica, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.|Instituto Nacional de Ciências e Tecnologia de Doenças Tropicais, INCT-DT, Salvador, Bahia, Brazil.
Selma Maria Bezerra
SM
Jerônimo
Departments of Internal Medicine and Pathology, University of Virginia, Charlottesville, VA, USA.
Richard D
RD
Pearson
D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology*; D004195:Disease Models, Animal; D006801:Humans; D007891:Leishmania / Q000276:immunology*; D016773:Leishmaniasis, Cutaneous / Q000517:prevention & control*; D007898:Leishmaniasis, Visceral / Q000517:prevention & control*; D016052:Protozoan Vaccines / Q000276:immunology*
D000953:Antigens, Protozoan; D016052:Protozoan Vaccines